Better Buy in 2024: The "Magnificent Seven" or the "Terrific 10"?
Microsoft, Apple, Nvidia, Amazon, Alphabet, Meta Platforms, and Tesla -- a group that Bank of America analyst Michael Hartnett dubbed the "Magnificent Seven," -- have taken the market by storm for an incredible outperformance in 2023 and a sustained run so far in 2024.
But what about the market's most valuable non-tech-focused companies?
Interestingly enough, if you look at the highest weighted companies in the S 500, it is dominated by the Magnificent Seven and Broadcom, a semiconductor company. After that, there's a slew of non-tech-focused companies. I'll call them the "Terrific 10," and they include Berkshire Hathaway, Eli Lilly (NYSE: LLY), JPMorgan Chase, UnitedHealth Group, Visa, Johnson Johnson, ExxonMobil, Home Depot, Mastercard, and Procter Gamble.
Source Fool.com
UnitedHealth Group Inc. Aktie
Die Community sieht UnitedHealth Group Inc. positiv: Viel mehr Buy- als Sell-Einschätzungen.
Für UnitedHealth Group Inc. ergibt sich ein leicht positives Potenzial, angesichts eines Kursziels von 543 € im Vergleich zu 468.45 €.
